Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes

被引:102
作者
Briley-Saebo, Karen C.
Mulder, Willem J. M.
Mani, Venkatesh
Hyafil, Fabien
Amirbekian, Vardan
Aguinaldo, Juan Gilberto S.
Fisher, Edward A.
Fayad, Zahi A.
机构
[1] Mt Sinai Sch Med, Ctr Translantat & Mol Imaging, Imaging Sci Labs, Dept Radiol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Ctr Cardiovasc Hlth, New York, NY 10029 USA
[4] NYU, Sch Med, Dept Med, Program Vasc Biol & Dis, New York, NY USA
[5] NYU, Sch Med, Dept Med, Ctr Prevent Cardiovasc Dis, New York, NY USA
关键词
atherosclerosis; molecular imaging; contrast agents; targeting; inflammation;
D O I
10.1002/jmri.20989
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The vulnerability or destabilization of atherosclerotic plaques has been directly linked to plaque composition. Imaging modalities, such as magnetic resonance (MR) imaging, that allow for evaluation of plaque composition at a cellular and molecular level, could further improve the detection of vulnerable plaque and may allow for monitoring the efficacy of antiatherosclerotic therapies. In this review we focus on MR imaging strategies for the detection and evaluation of atherosclerotic plaques and their composition. We highlight recent advancements in the development of MR pulse sequences, computer image analysis, and the use of commercially available MR contrast agents, such as gadopentic acid (Gd-DTPA), for plaque characterization. We also discuss molecular imaging strategies that are currently being used to design specific imaging probes targeted to biochemical and cellular markers of atherosclerotic plaque vulnerability.
引用
收藏
页码:460 / 479
页数:20
相关论文
共 170 条
[1]   Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI [J].
Accardo, A ;
Tesauro, D ;
Roscigno, P ;
Gianolio, E ;
Paduano, L ;
D'Errico, G ;
Pedone, C ;
Morelli, G .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (10) :3097-3107
[2]   Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates [J].
Aime, S ;
Barge, A ;
Cabella, C ;
Crich, SG ;
Gianolio, E .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (06) :509-518
[3]   Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations [J].
Aime, S ;
Cabella, C ;
Colombatto, S ;
Crich, SG ;
Gianolio, E ;
Maggioni, F .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (04) :394-406
[4]  
AMIRBEKIAN S, 2006, P 14 ANN M ISMRM SEA
[5]  
Amirbekian S, 2006, J CARDIOVASC MAGN R, V8, P11
[6]  
Amirbekian V, 2005, CIRCULATION, V112, pU286
[7]   Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents [J].
Anelli, PL ;
Lattuada, L ;
Lorusso, V ;
Schneider, M ;
Tournier, H ;
Uggeri, F .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2001, 12 (2-3) :114-120
[8]   Magnetic resonance imaging of cell surface receptors using targeted contrast agents [J].
Artemov, D ;
Bhujwalla, ZM ;
Bulte, JWM .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (06) :485-494
[9]   Dephased MRI [J].
Bakker, CJG ;
Seppenwoolde, JH ;
Vincken, KL .
MAGNETIC RESONANCE IN MEDICINE, 2006, 55 (01) :92-97
[10]   Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging [J].
Barkhausen, J ;
Ebert, W ;
Heyer, C ;
Debatin, JF ;
Weinmann, HJ .
CIRCULATION, 2003, 108 (05) :605-609